2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults

By afschroeder • April 2, 2026

Shumaker AH, Bhimraj A, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Shafer RW, Tien PC, Baden LR, Cawcutt K, Chiotos K, Dzierba AL, Hardy EJ, Johnson S, Kim AY, MacBrayne C, Martin GS, Nadig N, Nakamura MM, Oliveira CR, Pearson JC, Riley L, Shoham S, Tebas P, Willis Z, Wolf J, Loveless J, Morgan RL, Falck-Ytter Y, Gandhi RT. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults. Clin Infect Dis. 2026 Apr 1:ciaf680. doi: 10.1093/cid/ciaf680. Epub ahead of print. PMID: 41920902.

Tags: covid-19, guideline, Harbor UCLA, Infectious Diseases, molnupiravir, nirmatrelvir/ritonavir, Publications, remdesivir

Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia

Jang J, Nold T, Marshalek JP, Matthiesen J, Tomassetti S. Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia. J Oncol[...]

CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA

Ghotbi E, Hathaway QA, Jannatdoust P, Hadidchi R, Bancks MP, Bluemke DA, Budoff M, Post W, Hoffman EA, Smith BM, Lima JAC, Barr RG, Demehri[...]

Predictors of bleeding-related in-hospital complications after coronary angiography and percutaneous coronary intervention: A single-center retrospective cohort study in Iran

Andishmand A, Soltani MH, Mohammadi H, Namayandeh SM, Peigan P, Budoff M, Azimizadeh M, Andishmand M, Andishmand M. Predictors of bleeding-related in-hospital complications after coronary[...]